Welcome to our dedicated page for GLOBUS MEDICAL news (Ticker: GMED), a resource for investors and traders seeking the latest updates and insights on GLOBUS MEDICAL stock.
Globus Medical Inc. (NYSE: GMED) is a leading manufacturer of musculoskeletal implants and a pioneer in advancing spinal surgery through technological innovations. Founded in 2003, the company is renowned for its commitment to improving the quality of life for patients suffering from spinal disorders. With a focus on superior engineering and technology, Globus Medical offers a comprehensive suite of spinal products designed to facilitate pain-free, active living.
Globus Medical's product portfolio is divided into two main categories:
- Musculoskeletal Solutions: This segment includes an array of medical devices and instruments primarily used for spinal and orthopedic procedures. These products are the primary revenue drivers for the company, with a significant portion of sales generated within the United States.
- Enabling Technologies: This category features advanced computer systems developed to enhance surgical capabilities, providing surgeons with innovative tools to improve patient outcomes.
The company's dedication to innovation has made it the fastest-growing entity in the history of orthopedics. Recent achievements highlight this growth trajectory. Globus Medical announced an increase in its full-year fiscal 2023 revenue guidance to $1.55 billion, up from $1.125 billion, with non-GAAP fully diluted earnings per share reaffirmed at $2.30. Looking ahead, the company has updated its full-year 2024 revenue guidance to a range of $2.460 billion to $2.485 billion and non-GAAP fully diluted earnings per share between $2.75 and $2.85.
Globus Medical continues to foster strong partnerships and engage in cutting-edge projects aimed at expanding its market presence and technological capabilities. The company's headquarters are located in Audubon, PA, and it remains actively involved in the medical community through participation in teleconferences, investor calls, and industry events.
For more information about their latest products, financial performance, and upcoming events, you can visit the Globus Medical website at www.globusmedical.com.
Globus Medical (NYSE: GMED) will announce its Q1 2023 financial results on May 4, 2023, after market close. A teleconference is scheduled for the same day at 4:30 p.m. ET, allowing investors to discuss the results. The conference call will be streamed live via the company's website. Participants can also join via telephone by registering for the event. Globus Medical specializes in musculoskeletal solutions and was founded in 2003. The company emphasizes its dedication to product innovation for surgeon-assisted healing. A recording of the call will be available on the investor page following the event. For further information, details are accessible on the company’s website.
FAQ
What is the current stock price of GLOBUS MEDICAL (GMED)?
What is the market cap of GLOBUS MEDICAL (GMED)?
What does Globus Medical Inc. specialize in?
When was Globus Medical Inc. founded?
What are the main product categories of Globus Medical?
Where is Globus Medical Inc. headquartered?
How can I access the latest financial results of Globus Medical?
What is the company's revenue guidance for the fiscal year 2024?
How does Globus Medical contribute to spinal surgery advancements?
What percentage of Globus Medical's revenue comes from the United States?
How can investors participate in Globus Medical’s teleconference calls?
Where can I find more information about Globus Medical's products and services?
